The most common NPS Pharma email format is
[first_initial][last]
, which is being used by
98.11%
of NPS Pharma employees.
Other common email formats used by Nps Pharma's employees are
[first][last]
,
[first][last_initial]
,
[first]
,
[first]_[last]
,
[first].[last]
,
[first_initial][last_initial]
.
In total, Nps Pharma uses 7 work email formats.
Nps Pharma Email Format with Examples
Email format
Example
[first_initial][last]
jdoe@npsp.com
98%
[first][last]
johndoe@npsp.com
1%
Nps Pharma Questions
NPS Pharma's helpline number is (908) 450-5300
NPS Pharma's website is npsp.com
NPS Pharma's LinkedIn profile is https://www.linkedin.com/company/nps-pharmaceuticals
NPS Pharma's industry is
Biotechnology Research
NPS Pharma's top competitors are
Celgene,
Nps Do Brasil Farmaceutica Ltda.,
Ptc Therapeutics, Inc.,
Pint Pharma,
Ex- Viropharma Linkedin Page,
Amicus Therapeutics,
Takeda,
Ns Pharma, Inc.,
Praxis Precision Medicines, Inc.,
Shire.
NPS Pharma's support email address is investorrelations@shire.com
NPS Pharma's categories are Biotechnology Research
NPS Pharma's founding year is 1986
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.